SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PawPr who wrote (495)1/7/1998 6:22:00 PM
From: FNS  Read Replies (1) of 965
 
Bruce: <<IT'S A MOOT POINT UNTIL THE DRUG (AVAKINE ) IS APPROVED ANYWAY.>> You're right, but when the shareholders were led to believe
that a partner would be announced by year-end and it didn't happen, the shareholders got "impatient"! CNTO needs to complete the deal this QTR else the stock may dive again...any significant rallies might be based on soon to be announced partner news in addition to expected ReoPro earnings.

<<...SEVERAL COMPETING OFFERS>> Sounds like if this is/were true, then CNTO is in the driver's seat! Wonderful.

Any thoughts on when this drug will actually get approval?

Thanks for your insight.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext